PMID: 11930115Apr 4, 2002Paper

Effect of temozolomide on central nervous system relapse in patients with advanced melanoma

Melanoma Research
M J PaulM R Middleton

Abstract

Temozolomide has shown efficacy in the treatment of metastatic melanoma similar to that of dacarbazine (DTIC), the standard chemotherapy, but with the added benefit of penetration into the central nervous system (CNS). Isolated CNS relapse is increasingly a problem for patients who respond to biochemotherapy. By replacing DTIC with temozolomide in treatment regimens, the incidence of CNS relapse might be reduced. This hypothesis is difficult to test in a prospective randomized controlled trial because of the large number of patients that would be required. We have examined this question in a retrospective case control study, observing the rates of CNS relapse in advanced metastatic melanoma patients responding to DTIC- or temozolomide-based chemotherapy in three institutions. Twenty-one DTIC and 20 temozolomide responders were identified, and have been followed up for a median of 19.0 months (range 6.0-74.3 months). CNS relapse occurred in nine DTIC- and two temozolomide-treated patients, a statistically significant difference in favour of the new agent (P = 0.03). These results support the investigation of temozolomide as a replacement for DTIC in systemic treatment regimens for melanoma.

References

Aug 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M RichardsP Skosey
Jul 1, 1995·British Medical Bulletin·S M LeeN Thatcher
Jun 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J AtzpodienH Poliwoda
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N M BleehenM F Stevens
Oct 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S S LeghaN Papadopoulos
Jan 1, 1997·Cancer Chemotherapy and Pharmacology·M BowerM H Brampton
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P B ChapmanJ M Kirkwood
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R MiddletonN Thatcher
Mar 25, 2000·British Journal of Cancer·S B MiddletonR K Phillips

❮ Previous
Next ❯

Citations

May 2, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Carlos ConillTeresa Castel
Sep 17, 2005·HNO·E S Schultz, G Schuler
Jan 21, 2011·Journal of Neurology·Júlia MiróJordi Bruna
Mar 19, 2013·Current Treatment Options in Oncology·Sarah NicholasMichael Lim
Aug 21, 2007·Current Oncology Reports·Martin Majer, Wolfram E Samlowski
Feb 14, 2009·Disease-a-month : DM·William H FrishmanChristine Carosella
Oct 3, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J van den Bent
Jul 25, 2003·Autonomic Neuroscience : Basic & Clinical·Stephanie C Tjen-A-LooiJohn C Longhurst
Sep 1, 2008·Journal of Acupuncture and Meridian Studies·José F Rivas-VilchisRubén Román-Ramos
Nov 19, 2003·Current Opinion in Oncology·R Nagasubramanian, M Eileen Dolan
Jul 5, 2007·Neurosurgical Focus·Robert Cavaliere, David Schiff
Oct 31, 2002·Seminars in Oncology·Emma CattellMark R Middleton
Apr 27, 2013·Expert Review of Anticancer Therapy·Dionysis Papadatos-PastosAngus Dalgleish
Nov 3, 2006·Expert Review of Neurotherapeutics·Jan Drappatz, Patrick Y Wen
Aug 24, 2006·Expert Review of Anticancer Therapy·Nicole Mutter, Roger Stupp
Feb 3, 2007·Expert Opinion on Pharmacotherapy·Gregory M Richards, Minesh P Mehta
May 14, 2009·Expert Opinion on Drug Safety·Van Anh TrinhWen-Jen Hwu
Apr 24, 2013·Clinics in Dermatology·Jaclyn C FlaniganHarriet M Kluger
Jul 24, 2012·Cancer Treatment Reviews·Zuzana TatarXavier Durando
Oct 30, 2007·Neurologic Clinics·Teri D Nguyen, Lisa M DeAngelis
Nov 4, 2006·The Lancet Oncology·David W Ollila
May 26, 2009·Hematology/oncology Clinics of North America·Arvin S Yang, Paul B Chapman
Feb 19, 2005·Critical Reviews in Oncology/hematology·M J PayneM R Middleton
Dec 8, 2004·Critical Reviews in Oncology/hematology·Alicia TosoniAlba A Brandes
Nov 18, 2004·American Journal of Surgery·Tomio UenoDouglas S Tyler
Sep 1, 2004·Journal of the Neurological Sciences·Ulrich HerrlingerMichael Weller
Aug 22, 2015·Case Reports in Oncological Medicine·Rajesh BalakrishnanSamson S K Gaddam
Sep 7, 2016·Expert Review of Anticancer Therapy·Tobias WeissPatrick Roth
May 23, 2009·Journal of Cutaneous Medicine and Surgery·Michael SmylieUNKNOWN Canadian Expert Panel on Malignant Melanoma
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S DansonM R Middleton
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Jen HwuAlan N Houghton
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sanjiv S AgarwalaElaine M Rankin
Nov 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roland KaufmannUNKNOWN Dermatologic Cooperative Oncology Group
Nov 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert W WeberLynn E Spitler
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M F AvrilY Menu
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D BafaloukosP Kosmidis
Aug 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D AntonadouN Throuvalas
Jun 28, 2016·International Journal of Cancer. Journal International Du Cancer·Russell MaxwellMichael Lim
Jan 24, 2013·International Journal of Molecular Sciences·Maria CaffoFrancesco Tomasello

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.